Clinical Trials Network

The Association’s Clinical Trials Network (CTN) is a nationwide group of leading specialty centers in bronchiectasis and nontuberculous mycobacterial (NTM) lung disease designed to conduct clinical trials more efficiently and accelerate therapeutic developments. By providing centralized support for study design, site coordination, data management, and patient recruitment, the CTN helps clinical trials run more smoothly, efficiently, and with greater impact for patients.

Dive Deeper

Clinical Trials Network

The Association’s Clinical Trials Network (CTN) is designed to improve and enhance traditional operational aspects of clinical trials. The CTN provides a more efficient model for conducting clinical trials, reducing barriers to patient participation and accelerating the development of therapies.

The CTN is a nationwide network of bronchiectasis and NTM lung disease specialty centers vetted for participation in research studies and clinical trials. Dr. Charles (Chuck) Daley, the Association’s Chief Research Officer, oversees the CTN.

The CTN’s wide range of services to streamline and standardize clinical trial operations includes:

Steering committee establishment and management
Study design, protocol development, and implementation planning
Study site recruitment, contracting, and management
Data collection and management
Statistical support
Patient engagement and input
Accelerated patient recruitment

If you are interested in participating in the CTN, please submit this form and a member of the CTN team will contact you.

This page was reviewed on April 17, 2026 by the Bronchiectasis and NTM Association Content Review and Evaluation Committee.